Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Factor XI”

Showing 11 of 0 results

Not applicableStudy completedNCT00890812
What this trial is testing

Factor XI Levels in Acute Ischemic Stroke

Who this might be right for
Stroke
University of Utah 450
Large-scale testing (Phase 3)Not Yet RecruitingNCT07697599
What this trial is testing

Venous Thromboembolism (VTE) Prophylaxis With REGN7508 and REGN9933 in Adult and Adolescent Participants With a Peripherally Inserted Central Catheter (PICC)

Who this might be right for
Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals 1,908
Large-scale testing (Phase 3)Looking for participantsNCT07015905
What this trial is testing

REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults

Who this might be right for
Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals 2,000
Testing effectiveness (Phase 2)Study completedNCT04534114
What this trial is testing

Factor XI LICA to Reduce Events Such as Heart Attack and Stroke in Patients Whose Kidneys Are no Longer Able to Work as They Should and Require Treatment to Filter Wastes From the Blood: Focus is on the Safety of BAY2976217 and the Way the Body Absorbs, Distributes and Removes the Study Drug

Who this might be right for
End Stage Renal Disease Requiring Hemodialysis
Bayer 307
Large-scale testing (Phase 3)Looking for participantsNCT07318610
What this trial is testing

Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

Who this might be right for
Peripheral Artery Disease (PAD)
Regeneron Pharmaceuticals 7,050
Testing effectiveness (Phase 2)Study completedNCT05618808
What this trial is testing

A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants

Who this might be right for
Venous Thromboembolism
Regeneron Pharmaceuticals 373
Testing effectiveness (Phase 2)Study completedNCT03358030
What this trial is testing

ISIS 416858 Administered Subcutaneously to Participants With End-Stage Renal Disease (ESRD) on Hemodialysis

Who this might be right for
End-stage Renal Disease (ESRD)
Ionis Pharmaceuticals, Inc. 213
Not applicableUnknownNCT01114074
What this trial is testing

Thrombus Formation Under Different Flow-conditions

Who this might be right for
Thrombosis
Maastricht University Medical Center 46
Large-scale testing (Phase 3)Looking for participantsNCT07493304
What this trial is testing

Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers

Who this might be right for
Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals 1,600
Early research (Phase 1)Study completedNCT03582462
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of IONIS FXI-LRx in up to 84 Healthy Volunteers

Who this might be right for
Healthy Participants
Ionis Pharmaceuticals, Inc. 66
Early research (Phase 1)Study completedNCT05603195
What this trial is testing

A Trial to Learn if Single Ascending Intravenous (IV) Doses of REGN7508 Are Safe and Well Tolerated, and How it Works in the Body of Healthy Adult Participants

Who this might be right for
Healthy Volunteer
Regeneron Pharmaceuticals 80

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation